CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,633,473 | +75.2% | 492,047 | +6.2% | 0.00% | +50.0% |
| Q2 2023 | $8,350,792 | +23.0% | 463,418 | +9.6% | 0.00% | +100.0% |
| Q1 2023 | $6,789,990 | +5.5% | 422,789 | +20.2% | 0.00% | 0.0% |
| Q4 2022 | $6,437,189 | -4.0% | 351,759 | +3.0% | 0.00% | -50.0% |
| Q3 2022 | $6,706,000 | +8.6% | 341,482 | +3.1% | 0.00% | +100.0% |
| Q2 2022 | $6,177,000 | -11.2% | 331,245 | +4.5% | 0.00% | 0.0% |
| Q1 2022 | $6,958,000 | -24.1% | 317,037 | -1.7% | 0.00% | -50.0% |
| Q4 2021 | $9,163,000 | +44.0% | 322,506 | +6.7% | 0.00% | +100.0% |
| Q3 2021 | $6,365,000 | +15.6% | 302,345 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $5,507,000 | +25.8% | 292,155 | +1.9% | 0.00% | 0.0% |
| Q1 2021 | $4,378,000 | +13.8% | 286,577 | +5.1% | 0.00% | 0.0% |
| Q4 2020 | $3,848,000 | +38.5% | 272,637 | +53.8% | 0.00% | 0.0% |
| Q3 2020 | $2,778,000 | -14.6% | 177,312 | -4.5% | 0.00% | 0.0% |
| Q2 2020 | $3,252,000 | +514.7% | 185,623 | +415.2% | 0.00% | – |
| Q1 2020 | $529,000 | -41.2% | 36,032 | +0.5% | 0.00% | – |
| Q4 2019 | $899,000 | +72.6% | 35,847 | +3.4% | 0.00% | – |
| Q3 2019 | $521,000 | -46.0% | 34,664 | -10.2% | 0.00% | – |
| Q2 2019 | $964,000 | +63.1% | 38,586 | +48.5% | 0.00% | – |
| Q1 2019 | $591,000 | -15.0% | 25,978 | +12.1% | 0.00% | – |
| Q4 2018 | $695,000 | +53.4% | 23,180 | +46.6% | 0.00% | – |
| Q3 2018 | $453,000 | – | 15,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 820,720 | $17,276,000 | 7.15% |
| 5AM Venture Management, LLC | 1,362,286 | $28,676,000 | 5.82% |
| Bain Capital Life Sciences Investors, LLC | 1,679,701 | $35,358,000 | 2.19% |
| Opaleye Management Inc. | 402,113 | $8,464,000 | 1.58% |
| FRAZIER MANAGEMENT LLC | 851,306 | $17,920,000 | 1.43% |
| Perceptive Advisors | 3,963,517 | $83,432,000 | 1.21% |
| Altium Capital Management LP | 193,000 | $4,063,000 | 1.07% |
| MPM BioImpact LLC | 298,392 | $6,281,000 | 0.97% |
| SPHERA FUNDS MANAGEMENT LTD. | 548,643 | $11,549,000 | 0.97% |
| Ghost Tree Capital, LLC | 150,000 | $3,158,000 | 0.92% |